References
- Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr. Infect. Dis. J.20(1), 63–75 (2001).
- Acierno JP, Braden BC, Klinke S, Goldbaum FA, Cauerhff A. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies. J. Mol. Biol.374, 130–146 (2007).
- McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature348, 552–554 (1990).
- Burton DR, Barbas CF 3rd, Persson MA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic individuals. Proc. Natl Acad. Sci. USA88, 10134–10137 (1991).
- Jespers LS, Roberts A, Mahler SM, Winter G, Hoogenboom HR. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Nat. Biotechnol.12(9), 899–903 (1994).
- Cortese R, Monaci P, Luzzago A et al. Selection of biologically active peptides by phage display of random peptide libraries. Curr. Opin. Biotechnol.7, 616–621 (1996).
- Fisch I, Kontermann RE, Finnern R et al. A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage. Proc. Natl Acad. Sci. USA93(15), 7761–7766 (1996).
- Folgori A, Tafi R, Meola A et al. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J.13(9), 2236–2243 (1994).
- Irving RA, Coia G, Roberts A, Nuttall SD, Hudson PJ. Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J. Immunol. Methods248(1–2), 32–45 (2001).
- Gold L. mRNA display: diversity matters during in vitro selection. Proc. Natl Acad. Sci. USA98(9), 4825–4826 (2001).
- Fukuda I, Kojoh K, Tabata N et al.In vitro evolution of single-chain antibodies using mRNA display. Nucleic Acids Res.34(19), e127 (2006).
- Douthwaite JA, Groves MA, Dufner P, Jermutus L. An improved method for an efficient and easily accessible eukaryotic ribosome display technology. Protein Eng. Des. Sel.19(2), 85–90 (2006).
- Haroun M, El-Sayed MM. Measurement of IgG levels can serve as a biomarker in newly diagnosed diabetic children. J. Clin. Biochem. Nutr.41(1), 56–61 (2006).
- Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.25, 1271–1277 (1982).
- Desmetz C, Maudelonde T, Mangé A, Solassol J. Identifying autoantibody signatures in cancer: a promising challenge. Expert Rev. Proteomics6(4), 377–386 (2009).
- Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun. Rev.7, 616–620 (2008).
- Anderson L, Anderson NG. The human plasma proteome. Mol. Cell. Proteomics1, 845–867 (2002).
- Zhu H, Snyder M. Protein arrays and microarrays. Curr. Opin. Chem. Biol.5(1), 40–45 (2001).
- Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J. Proteome Res.4(4), 1123–1133 (2005).
- Hudson ME, Pozdnyakova I, Haines K et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl Acad. Sci. USA104(44), 17494–17499 (2007).
- Kijanka G, Murphy D. Protein arrays as tools for serum autoantibody marker discovery in cancer. J. Proteomics72, 936–944 (2009).
- Li L, Chen A, Chaudhuri A et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. transplantation89(3), 312–319 (2010).
- Caiazzo RJ Jr, Tassinari OW, Ehrlich JR, Liu BC. Autoantibody microarrays for biomarker discovery. Expert Rev. Proteomics4(2), 261–272 (2007).
- Gnjatic S, Ritter E, Büchler MW et al. Seromic profiling of ovarian and pancreatic cancer. Proc. Natl Acad. Sci. USA107(11), 5088–5093 (2010).
- Andresen H, Grotzinger C. Deciphering the antibodyome – peptide arrays for serum antibody biomarker diagnostics. Curr. Proteomics6, 1–12 (2009).
- Andresen H, Grötzinger C, Zarse K, Kreuzer OJ, Ehrentreich-Förster E, Bier FF. Functional peptide microarrays for specific and sensitive antibody diagnostics. Proteomics6(5), 1376–1384 (2006).
- Schaller RR. Moore’s law: past, present and future. IEEE Spectrum34(6), 52–59 (1997).